SEC Filings TLDR

Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.

Currently we only process 8-K, 6-K, Schedule 13G. We will support more forms in the future.

2025-08-01AU6-KAngloGold Ashanti Q2 2025 Earnings Release Investor PresentationMEDIUM
AngloGold Ashanti plc, a foreign private issuer, filed a Form 6-K with the SEC for the month of August 2025. The filing includes the Q2 2025 Earnings Release Investor Presentation, which provides detailed financial and operational results for the second quarter of 2025. The presentation is intended for investors and st...
2025-08-01AU6-KAngloGold Ashanti Q2 2025 Operating StatisticsMEDIUM
AngloGold Ashanti plc reported its operating statistics for the second quarter and first half of 2025. The report includes detailed data on gold production, gold sold, total cash costs, all-in sustaining costs, and capital expenditures across its managed operations and non-managed joint ventures. Key highlights include...
2025-08-01AU6-KAngloGold Ashanti Q2 2025 Earnings Release Highlights Strong PerformanceHIGH
AngloGold Ashanti plc reported a significant increase in its Q2 2025 earnings, driven by a 21% year-on-year rise in gold production and a 149% increase in free cash flow to $535 million. The company achieved a 92% reduction in adjusted net debt, which now stands at $92 million. Key operational highlights include a 25% ...
2025-08-01AU6-KAngloGold Ashanti 2025 Interim Report HighlightsHIGH
AngloGold Ashanti's 2025 Interim Report for the six months ended 30 June 2025 shows significant improvements in gold production and financial performance. Gold production from managed operations increased by 286,000 ounces to 879,000 ounces, driven by higher production in Africa, particularly at Sukari, which was acqui...
2025-08-01BABA6-KAlibaba's July-August 2025 Share RepurchasesMEDIUM
Alibaba Group Holding Limited filed a Form 6-K on August 1, 2025, disclosing multiple share repurchases executed between July 14 and July 31, 2025, under a board-authorized mandate. The company repurchased 4,087,504 shares in mid-July at prices ranging from $13.53 to $14.99 per share, followed by additional buybacks of...
2025-08-01LI6-KLi Auto Inc. July 2025 Delivery UpdateMEDIUM
Li Auto Inc. announced that it delivered 30,731 vehicles in July 2025, bringing its cumulative deliveries to 1,368,541. The company officially launched the Li i8, a six-seat battery electric family SUV, on July 29, 2025, with deliveries expected to begin on August 20, 2025. As of July 31, 2025, Li Auto had 535 retail s...
2025-07-31ZTO6-KZTO Express (Cayman) Inc. Announces Board Meeting and Earnings ReleaseMEDIUM
ZTO Express (Cayman) Inc. has announced that a board meeting will be held on August 19, 2025, to approve the unaudited financial results for the second quarter and the first six months of 2025. The results will be released on August 20, 2025, before the trading hours of The Stock Exchange of Hong Kong Limited. An earni...
2025-07-31WF6-KWoori Financial Group Inc. 2024 Sustainability ReportMEDIUM
On July 31, 2025, Woori Financial Group Inc. released the English version of its 2024 Sustainability Report on its official website. The report highlights the company's efforts and achievements in sustainability, reflecting its commitment to environmental, social, and governance (ESG) principles. This report is part of...
2025-07-31VOD6-KVodafone Group PLC Director Share TransactionsMEDIUM
Vodafone Group PLC reported multiple transactions involving its directors and persons discharging managerial responsibilities. The transactions primarily involved the vesting of conditional share awards under the Global Incentive Plan and the sale of shares to satisfy tax withholding obligations. Key individuals involv...
2025-07-31UL6-KUnilever PLC Supplement PublicationMEDIUM
Unilever PLC has published a Supplement dated 31 July 2025, relating to the U.S.$25,000,000,000 Debt Issuance Programme of Unilever Finance Netherlands B.V., Unilever Capital Corporation, and Unilever PLC (as Issuers) and Unilever PLC and Unilever United States, Inc. (as Guarantors). The Supplement has been approved by...
2025-07-31UL6-KUnilever PLC 2025 First Half ResultsHIGH
Unilever PLC reported its first half results for 2025, showing underlying sales growth (USG) of 3.4%, with volume growth of 1.5% and price growth of 1.9%. Turnover was €30.1 billion, down 3.2% due to adverse currency impacts and net disposals. The company achieved a strong gross margin of 45.7%, which supported increas...
2025-07-31TS6-KTenaris 2025 Second Quarter ResultsHIGH
Tenaris S.A. announced its financial results for the second quarter of 2025, reporting net sales of $3.086 billion, a 6% increase from the previous quarter. Operating income rose to $583 million, and net income reached $542 million, marking a 5% increase. The company's EBITDA stood at $733 million, with an EBITDA margi...
2025-07-31TRVG6-Ktrivago N.V. Completes Acquisition of Holisto LimitedMEDIUM
On July 31, 2025, trivago N.V. completed the acquisition of Holisto Limited for approximately €22.3 million (USD 25.5 million). Holisto, an AI-driven travel technology platform, serves as a hotel rate aggregator and white-label booking engine provider. As a result of this transaction, Holisto has become a wholly owned ...
2025-07-31TIMB6-KTIM S.A. Quarterly Financial Report as of June 30, 2025HIGH
TIM S.A. reported its quarterly financial results for the period ending June 30, 2025. The company achieved a net revenue of R$12.99 billion, a 4.8% year-over-year increase, driven by growth in mobile services revenue. Net profit for the quarter stood at R$1.77 billion, a significant rise compared to the same period in...
2025-07-31TIMB6-KTIM S.A. Form 6-K FilingLOW
TIM S.A., a foreign private issuer, filed a Form 6-K with the U.S. Securities and Exchange Commission on July 30, 2025. The filing indicates that the company will file annual reports under Form 20-F. The report was signed by Alberto Mario Griselli, who serves as the Chief Executive Officer, Chief Financial Officer, and...
2025-07-31TIMB6-KTIM S.A. Form 6-K FilingLOW
TIM S.A., a foreign private issuer, filed a Form 6-K with the U.S. Securities and Exchange Commission on July 30, 2025. The filing was submitted electronically and does not include any additional documents or exhibits. The report was signed by Alberto Mario Griselli, who serves as the Chief Executive Officer, Chief Fin...
2025-07-31TIMB6-KTIM S.A. Board of Directors Meeting Minutes - July 30, 2025MEDIUM
The Board of Directors of TIM S.A. held a meeting on July 30, 2025, at the company's headquarters in Rio de Janeiro. The meeting was attended by key members of the board, including Chairman Nicandro Durante and Secretary Fabiane Reschke. The agenda included acknowledging the activities of various committees such as the...
2025-07-31TIMB6-KElection of New Investor Relations Officer at TIM S.A.MEDIUM
TIM S.A. (B3: TIMS3; NYSE: TIMB) announced the election of Mr. Vicente de Moraes Ferreira as the new Investor Relations Officer (DRI), effective August 1, 2025. Mr. Ferreira, who holds a degree in electronics and computer engineering from the Federal University of Rio de Janeiro, an MBA from Fundação Getúlio Vargas, an...
2025-07-31TIMB6-KTIM S.A. Fiscal Council Meeting Minutes - July 30, 2025MEDIUM
The Fiscal Council of TIM S.A. held a meeting on July 30, 2025, at the company's head office in Rio de Janeiro. The meeting was attended by the regular members of the Fiscal Council, the Secretary, and the Chairman of the Board of Directors. The agenda included presentations on the company's tax, regulatory, civil, and...
2025-07-31TAL6-KTAL Education Group Q1 Fiscal 2026 Financial ResultsHIGH
TAL Education Group (NYSE: TAL) announced its unaudited financial results for the first quarter of fiscal year 2026, ended May 31, 2025. The company reported net revenues of $575.0 million, a 38.8% increase from $414.2 million in the same period last year. Income from operations was $14.3 million, compared to a loss of...
2025-07-31TAK6-KInadvertent Disclosure of Oveporexton (TAK-861) AbstractMEDIUM
Takeda Pharmaceutical Company Limited reported an inadvertent disclosure of an abstract related to their Phase 3 TAK-861-3002 study of oveporexton (TAK-861) for narcolepsy type 1. The abstract, which was slated for presentation at the World Sleep 2025 congress, was mistakenly published on the World Sleep Congress websi...
2025-07-31SQNS6-KSequans Communications Preliminary Q2 2025 Financial ResultsMEDIUM
Sequans Communications S.A. (NYSE: SQNS) announced its preliminary financial results for the second quarter ended June 30, 2025. The company reported revenue of $8.1 million, a 1.1% increase from the previous quarter but a 15.8% decrease year-over-year. Gross margin stood at 64.4%, slightly down from 64.5% in Q1 2025 a...
2025-07-31SNY6-KSanofi's Sarclisa Approved in the EU for Multiple Myeloma TreatmentHIGH
In July 2025, Sanofi announced that its drug Sarclisa (isatuximab) has been approved by the European Commission for the treatment of transplant-eligible newly diagnosed multiple myeloma (NDMM). This approval is based on the GMMG-HD7 phase 3 study, which demonstrated that Sarclisa, in combination with bortezomib, lenali...
2025-07-31SNY6-KSanofi 2025 Half-Year Financial ReportHIGH
Sanofi's 2025 half-year financial report highlights the company's financial performance for the first six months of the year. The report includes condensed consolidated financial statements, which show a net income of €5.8 billion, a significant increase from €2.3 billion in the same period of 2024. The company's net s...
2025-07-31SNY6-KSanofi Q2 2025 Financial and Operational HighlightsHIGH
Sanofi reported strong Q2 2025 results with a 10.1% increase in sales at constant exchange rates (CER), driven by key products like Dupixent, which saw a 21.1% growth in sales. The company achieved a business EPS of €1.59, up 8.3% at CER. Sanofi also made significant progress in its pipeline, with three regulatory appr...